EUVIMEDEUVIMED entdecken
Crossref

Proton pump inhibitors may contribute to progression or development of chronic obstructive pulmonary disease—A sequence symmetry analysis approach

Jack L Janetzki iD, Matthew J Sykes iD, Michael B Ward iD, Nicole L Pratt iD

Journal of Clinical Pharmacy and Therapeutics · 2021-12 · 46 (6) · 1687-1694

DOI: 10.1111/jcpt.13520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 25.08.2021. Verfasst von Jack L Janetzki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedBronchodilator AgentsFemaleHumansMaleMiddle AgedProton Pump InhibitorsPulmonary Disease, Chronic Obstructive

Stichwörter der Autor:innen

chronic obstructive pulmonary diseasepharmacoepidemiologypharmacyproton pump inhibitor

Substanzen

Bronchodilator AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia.
  • UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.

ORCID-Profile: Jack L Janetzki, Matthew J Sykes, Michael B Ward, Nicole L Pratt

Zitieren

APA

Janetzki, J. L., Sykes, M. J., Ward, M. B., & Pratt, N. L. (2021). Proton pump inhibitors may contribute to progression or development of chronic obstructive pulmonary disease—A sequence symmetry analysis approach. Journal of Clinical Pharmacy and Therapeutics, 46(6), 1687-1694. https://doi.org/10.1111/jcpt.13520

Vancouver

Janetzki JL, Sykes MJ, Ward MB, Pratt NL. Proton pump inhibitors may contribute to progression or development of chronic obstructive pulmonary disease—A sequence symmetry analysis approach. Journal of Clinical Pharmacy and Therapeutics. 2021;46(6):1687-1694. doi:10.1111/jcpt.13520

BibTeX
@article{Janetzki2021,
  author = {Janetzki, Jack L and Sykes, Matthew J and Ward, Michael B and Pratt, Nicole L},
  title = {Proton pump inhibitors may contribute to progression or development of chronic obstructive pulmonary disease—A sequence symmetry analysis approach},
  journal = {Journal of Clinical Pharmacy and Therapeutics},
  year = {2021},
  volume = {46},
  number = {6},
  pages = {1687--1694},
  doi = {10.1111/jcpt.13520}
}
Kostenlos starten →